Integrated DNA Technologies Launches First Cas9 Enzyme That Drastically Reduces CRISPR Off-Target Effects Without Significant Loss Of On-Target Activity Post author:Sam Post published:July 31, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Struggling Acorda Adopts Plan To Fend Off Takeover Attempts August 31, 2017 Novogen Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs April 5, 2017 <b>KD&A</b> Release: Meeting Medical Software Regulatory Requirements July 20, 2017